الفهرس | Only 14 pages are availabe for public view |
Abstract In this study, the effects of early renin-angiotensin system blockade using angiotensinconverting enzyme (ACE) inhibitor lisinopril and/or angiotensin receptor blocker valsartan on renal nephrin and vascular endothelial growth factor (VEGF-A) gene expression were investigated in diabetic-hypertensive rats. Diabetes and hypertension were induced in adult Wistar rats using streptozotocin (STZ) (45 mg/kg, i.p.) and Nω-nitro-L-arginine methyl ester (L-NAME) (60 mg/kg/12 h) for 4 consecutive days. Experimental animals were allocated into six groups (n=6): normal control, diabetic control, diabetic-hypertensive control, and (lisinopril-, valsartan- and combination-) treated diabetic-hypertensive groups (5 mg/kg/drug/day, p.o., for 21 days). Blood glucose, blood pressure, body weight, serum albumin, creatinine, total protein and urea were measured and recorded every week. Nephrin and VEGF-A gene expression was measured using real-time polymerase chain reaction. Renal nephrin protein was measured using ELISA as well as nephrin immunostaining. |